| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/13/2005 | CN1210307C Humanized anti-CD 20 monoclonal antibody |
| 07/13/2005 | CN1210062C Pig erysipelothrix rhusiopathiae antigen and vaccine composition thereof |
| 07/13/2005 | CN1210037C Glucosamine and egg for reducing inflammation |
| 07/12/2005 | US6917882 Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| 07/12/2005 | US6916961 Compound for use in the prevention and treatment of respiratory and nervous system disorders |
| 07/12/2005 | US6916917 Chimeric pro-caspases and methods of using same |
| 07/12/2005 | US6916913 Dorsalin-1 polypeptide and uses thereof |
| 07/12/2005 | US6916908 Mixture comprising blood protein of marine gastropod for treating tumors; immunotherapy; immunostimulants |
| 07/12/2005 | US6916907 Comprises osteoclastogenesis inhibitory factor (OCIF) polypeptide for diagnosis and treatment of bone disorders |
| 07/12/2005 | US6916904 Inhibition of immune complex formation |
| 07/12/2005 | US6916789 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 07/12/2005 | US6916788 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 07/12/2005 | US6916648 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/12/2005 | US6916625 Artery- and vein-specific proteins and uses therefor |
| 07/12/2005 | US6916624 Antibody for use in the diagnosis and treatment of cancer |
| 07/12/2005 | US6916622 Screening method and a screening system capable of selecting agents capable of interfering with this protein-protein interaction; selection of agents capable of modulating this protein-protein interaction for treatment and control of PV |
| 07/12/2005 | US6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 07/12/2005 | US6916607 Gene controlling androgen |
| 07/12/2005 | US6916489 Active agent transport systems |
| 07/12/2005 | US6916478 Prevention, therapy infectious diseases; insertion of nucleic acids into target cells |
| 07/12/2005 | US6916477 Vaccine containing attenuated virus; induction antibodies; veterinary medicine |
| 07/12/2005 | US6916476 Keyhole limpet hemocyanin (klh); anticancer agents; treating melanoma |
| 07/12/2005 | US6916474 Binds immunologically to bacillus anthracis protective antigen with an affinity kd of 140-21 pm determined by surface plasmon resonance |
| 07/12/2005 | US6916462 Administering conjugate of the entity and a light-generating moiety; immobilizing the subject within the detection field of a photodetector device; measuring photon emission with photodetectorl; constructing image |
| 07/12/2005 | CA2452172A1 Methods and compositions for modulating cell activation and uses thereof |
| 07/12/2005 | CA2259047C Innoculation kits for avoiding maternal immunity |
| 07/12/2005 | CA2201419C Human t-cell lymphotropic virus type i envelope protein and human monoclonal antibodies specific therefor |
| 07/12/2005 | CA1341485C Fusion proteins utilizing the decay accelerating factor membrane binding domain |
| 07/07/2005 | WO2005061697A1 Process for producing engineered targeted t cell and medicine |
| 07/07/2005 | WO2005061542A2 Detection of cd20 in transplant rejection |
| 07/07/2005 | WO2005061541A1 Anti-igf-i receptor antibody |
| 07/07/2005 | WO2005061538A2 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 07/07/2005 | WO2005061534A2 Improved tuberculosis vaccines |
| 07/07/2005 | WO2005061482A1 Ecstasy haptens and immunogens |
| 07/07/2005 | WO2005061000A1 Remedy for angitis |
| 07/07/2005 | WO2005060999A2 Detection of cd20 in therapy of autoimmune diseases |
| 07/07/2005 | WO2005060998A2 Methods of modulating cytokine activity; related reagents |
| 07/07/2005 | WO2005060995A2 Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 07/07/2005 | WO2005060994A1 Immunotherapy for food allergy by reduced and alkylated food allergens |
| 07/07/2005 | WO2005060993A1 Synthetic protein as tumor-specific vaccine |
| 07/07/2005 | WO2005060966A1 Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist |
| 07/07/2005 | WO2005060764A1 Method for improving body weight uniformity and increasing carcass yield in animals |
| 07/07/2005 | WO2005060713A2 Method of inhibiting candida-related infections using donor selected or donor stimulated immunoglobulin compositions |
| 07/07/2005 | WO2005060642A2 Rationally designed antibodies |
| 07/07/2005 | WO2005060541A2 Peptides and methods for inducing cellular resistance to infection |
| 07/07/2005 | WO2005060520A2 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF |
| 07/07/2005 | WO2005060377A2 Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| 07/07/2005 | WO2005060375A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/07/2005 | WO2005060368A2 Humanized anti-ccr2 antibodies and methods of use |
| 07/07/2005 | WO2005060330A2 Freeze-dried vaccine adjuvant |
| 07/07/2005 | WO2005060328A2 ENCODING NUCLEOTIDES OF GENES FROM THE CHROMOSOME OF THE BACTERIUM Mycoplasma hyopneumoniae, EXPRESSION AND ACTIVITY OF THE POLYNUCLEOTIDES AND THEIR APPLICATIONS |
| 07/07/2005 | WO2005050198A3 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 07/07/2005 | WO2005049078A3 Immunoglobulin preparations having increased stability |
| 07/07/2005 | WO2005044844A3 Protozoan strains of reduced virulence and use thereof |
| 07/07/2005 | WO2005042728A3 Immortalized avian cell lines for virus production |
| 07/07/2005 | WO2005035720A3 Methods and use of binding components for improving assay specificity |
| 07/07/2005 | WO2005035556A3 Sars-coronavirus virus-like particles and methods of use |
| 07/07/2005 | WO2005030806A3 Norovirus monoclonal antibodies and peptides |
| 07/07/2005 | WO2005027961A3 Chlamydia pmpd autotransporter and its role as adhesin |
| 07/07/2005 | WO2005020785A3 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis |
| 07/07/2005 | WO2005016266A3 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 07/07/2005 | WO2005014776A3 Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 07/07/2005 | WO2004110356A3 Methods for modulating cell-to-cell adhesion using an agonist of c1inh-type protein activity |
| 07/07/2005 | WO2004100868A3 Method of treating transplant rejection |
| 07/07/2005 | WO2004091500A3 Delivery of immune response modifier compounds |
| 07/07/2005 | WO2004078909A3 Identification of antigen epitopes |
| 07/07/2005 | WO2004072296A3 Compositions for modulating immune cell activity and methods for detection thereof |
| 07/07/2005 | WO2004071439A3 Immunoglobulin formulation and method of preparation thereof |
| 07/07/2005 | WO2004053064A3 Engineered fab'fragment anti-tumor necrosis factor alpha in combination with disease modifying anti-rheumatic drugs |
| 07/07/2005 | WO2004026265A9 Compositions and methods for treatment of herpesvirus infections |
| 07/07/2005 | WO2003089583A3 Tissue specific genes and gene clusters |
| 07/07/2005 | WO2003083069A8 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 07/07/2005 | WO2003061571A3 Combination il-2/anti-herz antibody therapy for cancers characterized by overexpression of the her2 receptor protein |
| 07/07/2005 | US20050150014 Generating mite allergen in plant for use in treatment and prevention of allergies and respiratory system disorders |
| 07/07/2005 | US20050148541 Treatment and prevention of HIV and other viral infections |
| 07/07/2005 | US20050148538 Adjuvant formulations for bacterial and virus vaccines and method of making same |
| 07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
| 07/07/2005 | US20050148529 Nucleic acid immunization |
| 07/07/2005 | US20050148527 Catalytic nucleic acids; ribozymes; translation inhibition; gene expression inhibition; for treating cardiovascular disease; for neovascularization induction in heart tissue |
| 07/07/2005 | US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148030 Using computer generated models to design immunoglobulin specific ligands; immunosuppressants; rational drug design |
| 07/07/2005 | US20050148028 Matrix membrane fusion protein with improved solubility in membrane-free and detergent-free aqueous environments for use in identifying modulators of membrane transport |
| 07/07/2005 | US20050148024 Using hormone peptides concentrations as diagnostic tools in detection of cardiovascular disorders |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050148012 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/07/2005 | US20050147999 Lyme disease vaccines |
| 07/07/2005 | US20050147988 Recombinant protein for use as tool in detection of helicobacter infection; immunodiagnostics |
| 07/07/2005 | US20050147628 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 07/07/2005 | US20050147627 Toll-like receptor 5 ligands and methods of use |
| 07/07/2005 | US20050147626 administering clostridium to nerves for treatment of epilepsy and pain |
| 07/07/2005 | US20050147624 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue |
| 07/07/2005 | US20050147623 Recombinant parainfluenza virus expression systems and vaccines |
| 07/07/2005 | US20050147622 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| 07/07/2005 | US20050147621 Use of bacterial 5' untranslated regions for nucleic acid expression |
| 07/07/2005 | US20050147618 comprising blood coagulation factors and segments of an immunoglobulin fragments, used for treating hemostatic disorders |
| 07/07/2005 | US20050147613 using bispecific antibodies comprising an antibody having binding specificity which confers the ability to cross the blood-brain barrier, and a second antibody conferring the ability to bind to beta -amyloid epitopes, used for the treatment of Alzheimer's disease or Down's syndrome |
| 07/07/2005 | US20050147612 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 07/07/2005 | US20050147610 Polypeptides comprising antigen binding domains for diagnosis, prevention and treatment of inflammation, skin, respiratory, kidney, cardiovascular, nervous system and pancreatic disorder |
| 07/07/2005 | US20050147608 modulating the activity of a nuclear factor kappa beta (NF-kB) polypeptide in cells by contacting with phosphoserine peptide or mimetics, for the treatment of cell proliferative disorders, immune response disorders and inflammatory disorders |
| 07/07/2005 | US20050147607 administering interleukin antagonists, for prophylaxis of respiratory system disorders |